Evofem Biosciences (EVFM) News Today $0.02 +0.01 (+49.04%) As of 09/12/2025 03:57 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EVFM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media PlatformsSeptember 11, 2025 | prnewswire.comEvofem Biosciences, Inc.: Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder MeetingSeptember 9, 2025 | finanznachrichten.deEvofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder MeetingSeptember 9, 2025 | prnewswire.comEvofem Biosciences Updates Merger Agreement with AditxtAugust 26, 2025 | msn.comIllinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed LawAugust 21, 2025 | prnewswire.comEvofem says FDA Orange Book lists patent for Solosec treatmentAugust 19, 2025 | msn.comFDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and TrichomoniasisAugust 19, 2025 | prnewswire.comEvofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business UpdateAugust 14, 2025 | prnewswire.comEvofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE ConferenceAugust 5, 2025 | prnewswire.comPhexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary MommyJuly 15, 2025 | finance.yahoo.comEvofem Biosciences, Inc. (EVFM) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comWindtree Contracts Chinese Firm to Make Evofem's ContraceptiveJune 26, 2025 | marketwatch.comEvofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug StoreJune 23, 2025 | prnewswire.comEvofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of DirectorsJune 9, 2025 | businesswire.comEvofem Signs SOLOSEC License Agreement for Middle East with Pharma 1May 21, 2025 | prnewswire.comEvofem Biosciences Inc. Q1 Earnings SummaryMay 17, 2025 | nasdaq.comEvofem Biosciences Reports Q1 2025 EarningsMay 16, 2025 | tipranks.comEvofem Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 15, 2025 | prnewswire.comEvofem Biosciences Amends Agreement with UAE PartnerMay 8, 2025 | tipranks.comEvofem Biosciences to Present at Emerging Growth ConferenceApril 14, 2025 | prnewswire.comEvofem Biosciences Inks Amendment with Windtree for PHEXXI SupplyApril 5, 2025 | investing.comEvofem Signs Sourcing Partnership With Windtree, Expects To Reduce Production Cost Of Phexxi By 60%March 28, 2025 | nasdaq.comEvofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree TherapeuticsMarch 26, 2025 | prnewswire.comEvofem Biosciences Reports Sales Growth and Strategic AdvancesMarch 24, 2025 | tipranks.comWindtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved ProductMarch 20, 2025 | globenewswire.comEvofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTOFebruary 13, 2025 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024November 16, 2024 | finanznachrichten.deEvofem Biosciences Reports Q3 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt announces Evofem secures voting agreements with investors for mergerNovember 6, 2024 | markets.businessinsider.comEvofem Secures Investor Support for Proposed Merger through Voting AgreementsNovember 6, 2024 | prnewswire.comEvofem Biosciences Faces Merger and Credit ChallengesNovember 1, 2024 | markets.businessinsider.comAditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with EvofemOctober 28, 2024 | finance.yahoo.comAditxt and Evofem partner to launch endometriosis diagnostic in 2025September 24, 2024 | msn.comEvofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by AditxtSeptember 24, 2024 | finance.yahoo.comAditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025September 20, 2024 | finance.yahoo.comInvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic TestSeptember 20, 2024 | msn.comAditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024September 9, 2024 | uk.finance.yahoo.comEvofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral SolutionAugust 20, 2024 | prnewswire.comEvofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Second Quarter of 2024August 15, 2024 | finanznachrichten.deEvofem Biosciences Announces Financial Results for the Second Quarter of 2024August 14, 2024 | prnewswire.comEvofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1stJuly 25, 2024 | globenewswire.comEvofem Signs Phexxi® License Agreement for Middle East with Pharma 1July 23, 2024 | prnewswire.comLupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSECJuly 15, 2024 | prnewswire.comHello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's HealthcareJune 27, 2024 | prnewswire.comEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of MatterJune 11, 2024 | prnewswire.comEVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024May 15, 2024 | investorplace.comEvofem Biosciences Announces Financial Results for the First Quarter of 2024May 15, 2024 | prnewswire.comEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTOApril 18, 2024 | prnewswire.comEvofem Biosciences, Inc. (EVFM)April 17, 2024 | finance.yahoo.com Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EVFM Media Mentions By Week EVFM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVFM News Sentiment▼-0.010.94▲Average Medical News Sentiment EVFM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVFM Articles This Week▼40▲EVFM Articles Average Week Get the Latest News and Ratings for EVFM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Evofem Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Clearmind Medicine News InMed Pharmaceuticals News Onconetix News Jaguar Animal Health News Entero Therapeutics News Trinity Biotech News Silexion Therapeutics News PowerUp Acquisition News Evaxion A/S News Revelation Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVFM) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVFM Stock Alerts